CRP and rheumatoid arthritis: We find that molar concentration of the monomeric CRP is over 10,000-fold of RANKL in both CRPL and CRPH RA patients, indicating that the monomeric CRP is enough to neutralizing RANKL and the redundant free monomeric CRP would dominate osteoclastic activities in RA.